New report shows workforce being hit hard by diabetic eye disease 28 April 2015 The productivity of Australia’s workforce is being hit hard and may be even more so in the future by the impact of diabetic macular oedema (DME), according to a new report supported by Macular Disease Foundation Australia and Diabetes Australia. Key points: This year alone diabetic macular oedema (DME) is estimated to cost the country $2.07 billion in indirect economic costs, with a significant part due to reduced ability to work at full capacity and lost wellbeing caused by impaired vision.1 The impact is set to grow in coming years as the number of people living with diabetes is estimated to reach 2.45 million by 2030 and the prevalence of DME is estimated to rise by 42 per cent over the next 15 years.
Blog 18 November 2026 Make a splash: Water exercise for diabetes As the weather warms up, it can be less enticing to go for that walk or bike ride, so why... Continue Reading
Media releases 18 November 2026 Foundayo approval a welcome addition to GLP-1 treatment options Diabetes Australia has welcomed the TGA approval of Foundayo (orforglipron), a new oral GLP-1 receptor agonist for the management of type 2 diabetes and chronic weight management in eligible adults. Continue Reading
Blog 18 November 2026 Five days of easier meal decisions Discover five days of realistic meal ideas designed to help you enjoy a variety of foods, save time in the kitchen, and make nutritious choices with less stress and planning. Continue Reading